Clinical Trial Update: Bioequivalence of Eye Drops and Spray Administration of Vigamox [NA]

View source ↗

Summary

A completed clinical trial evaluated the bioequivalence of Vigamox when given as traditional eye drops versus spray administration in patients with cataracts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• VIGAMOX (Moxifloxacin hydrochloride)

Snippet

Sponsor: Advanced Ophthalmic Pharma | Conditions: Cataract | NA | Status: COMPLETED